Medical device company EndoSound has received an investment from the American Gastroenterological Association’s venture capital fund to expand and improve its endoscopic ultrasound technology.
EndoSound’s Vision System, a platform whose transducer transforms a conventional upper endoscope into a fully functional endoscopic ultrasound device, received FDA breakthrough device designation in July 2021, according to a Jan. 24 news release from the company. The platform has not been cleared by the FDA.
EndoSound will use the funding to improve Vision System’s access, reduce cost and increase safety, the release said.
Nanosonics has received FDA De Novo clearance for its new Coris system, a technology designed to improve the cleaning of…
Gastrointestinal procedures make up a huge share of the most commonly billed services at ASCs, according to a March 13…
The number of Medicare-certified, single-specialty gastroenterology ASCs grew by 122 nationwide from 2018 to 2023, according to data from a…
Comments are closed.